Investors / Australia / Tarnagulla Ventures
Tarnagulla Ventures
Venture capital · Melbourne, Australia · Asia Pacific
Tarnagulla Ventures is a venture capital firm that provides seed and venture capital to companies in the life science and healthcare space. It is headquartered in Melbourne, Australia, and focuses on bringing medical technology to the Australian and US markets.
Invests inHealthcare & Biotech
In its own wordslife scienceshealthcaretherapeuticsbiotechmedical technology
Your fit with Tarnagulla Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsTarnagulla Ventures lists 6 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 50% of its companies are based in United States. It invests most often alongside 7G BioVentures, Pivotal Life Sciences and Pontifax.
No funding round on record names Tarnagulla Ventures yet, so the figures come from its portfolio page.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 8th | 6 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Tarnagulla Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Azora Therapeutics develops therapies for serious immune-mediated and inflammatory diseases, including ulcerative colitis. | Healthcare & Biotech | Portfolio page | ||
| Jupiter Neurosciences, Inc. is a clinical-stage drug platform company focused on treating neuroinflammation. | Healthcare & Biotech | Portfolio page | ||
| LB Pharmaceuticals is developing medicines for brain disorders | Healthcare & Biotech | Portfolio page | ||
| Lubris BioPharma is a biopharmaceutical company developing recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age & inflammation-related conditions. | Healthcare & Biotech | Portfolio page | ||
| The company develops targeted therapies to stop oxidative tissue damage, a driver of blinding eye diseases and serious chronic conditions. | Healthcare & Biotech | Portfolio page | ||
| Prevatex is developing and bringing to market the next generation of probiotic-based biotherapeutics to establish, restore, and maintain a healthy microbiome. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- tarnagullaventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Tarnagulla Ventures' profile as data
Pull Tarnagulla Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/tarnagullaventures.com
# also
GET /v1/firms/tarnagullaventures.com/portfolio
GET /v1/firms/tarnagullaventures.com/coinvestors
GET /v1/firms/tarnagullaventures.com/news